ACP Condemns Events at Capitol Building, Calls for Peaceful Transition of Power to Protect Public Health
Statement attributable to:
Jacqueline W. Fincher, MD, MACP
President, »Æ¹ÏµÎµÎapp
WASHINGTON, Jan. 7 - The »Æ¹ÏµÎµÎapp (ACP) strongly condemns the acts of violence committed yesterday and the efforts to disrupt basic democratic processes in our nation’s capital. The images of the attack on our Capitol building, our lawmakers, and all those who work there are both disheartening and disturbing.
Annals of Internal Medicine: Single dose of vaccine may have greater population benefit than multiple doses
Many Americans cannot sleep — and the pandemic makes it worse
Doctor Wipes Away $650,000 in Debt From 200 Cancer Patients' Bills
In an Unprecedented Move, Seven National Primary Care Organizations Launch Joint Vision to Rewire Primary Care Financing
With COVID-19 as a catalyst, the organizations developed recommendations to fundamentally change the way primary care is financed, improve health equity and boost clinicians’ ability to offer seamlessly integrated care
ACP Says COVID-19 Relief Legislation Advances Essential Policies to Support Patients and Physicians
Statement attributable to:
Jacqueline W. Fincher, MD, MACP
President, »Æ¹ÏµÎµÎapp
ACP supports ACIP recommendation for second COVID-19 vaccine
PHILADELPHIA, Dec. 22 – The »Æ¹ÏµÎµÎapp (ACP) supports the recommendation of the Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and Prevention (CDC) for the use of the COVID-19 vaccine from Moderna, Inc. to be used in persons 18 and older in the U.S. under the Food and Drug Administration’s Emergency Use Authorization. ACP previously announced its support for the ACIP recommendations to the CDC for the use of the Pfizer-BioNTech COVID-19 vaccine.
ACP, Annals of Internal Medicine host virtual COVID-19 Vaccine Forum II for physicians
Panel offers timely, evidence-based advice for promoting vaccine confidence and uptake
ACP Supports ACIP Recommendation for COVID-19 Vaccination
PHILADELPHIA, Dec. 15, 2020 – The »Æ¹ÏµÎµÎapp (ACP), representing 163,000 internal medicine physicians, supports the recommendation of the Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and Prevention (CDC) for the use of the Pfizer-BioNTech COVID-19 vaccine in persons 16 and older in the U.S. under the Food and Drug Administration’s Emergency Use Authorization. ACP also supports the addition of an amendment to the 2021 Adult Immunization Schedule to include use of COVID-19 vaccines.